Social vulnerability and medication adherence in individuals with chronic obstructive pulmonary disease

Sevda Efil
ID
Email src
Ceren Mina Bükrük
ID
Ebru Özen
ID
Department of Nursing, Faculty of Health Sciences, Canakkale Onsekiz Mart University, Canakkale, Türkiye
Department of Nursing, Faculty of Health Sciences, Canakkale Onsekiz Mart University, Canakkale, Türkiye
Department of Nursing, Faculty of Health Sciences, Canakkale Onsekiz Mart University, Canakkale, Türkiye
Received: 9 February 2024 / Revised: 4 June 2024 / Accepted: 12 June 2024 / Published: 30 December 2024

Abstract

Introduction and aim. The association between social vulnerability and medication adherence in individuals with chronic obstructive pulmonary disease is unclear. The aim of this study was to show the correlation of social vulnerability and medication adherence in individuals with chronic obstructive pulmonary disease.

Material and methods. Data collection was conducted by face to face interview in November 2022 and May 2023. Social vulnerability and medication adherence were evaluated using the Social Vulnerability Scale and the Medication Adherence Report Scale respectively.

Results. The mean scores of individuals with chronic obstructive pulmonary disease for social vulnerability and medication adherence were 20.02±6.69 and 22.76±3.29 respectively. Levels of social vulnerability varied according to comorbidity, hypertension, heart failure, visit to emergency service in the last three months due to COPD exacerbation, and using herbal products instead of medication (p<0.05). Mean scores for medication adherence were lower in women, never smokers, and those who used herbal products instead of medication (p<0.05).

Conclusion. Having a higher level of social vulnerability is associated with worse medication adherence (r=-0.31, p<0.01). Individuals using herbal products are found to be at risk for social vulnerability and non-adherence to medication (p<0.05).

 

Cite

Efıl S, Bükrük CM, Özen E. Social vulnerability and medication adherence in individuals with chronic obstructive pulmonary disease. Eur J Clin Exp Med. 2024;22(4):776–784. doi: 10.15584/ejcem.2024.4.13.

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited